文献速递肾移植

肾移植后交感神经再支配与降压药负担及间质纤维化相关

Sympathetic Reinnervation is Associated With Antihypertensive Treatment Burden and Interstitial Fibrosis After Kidney Transplantation.
PubMed 文献 · Kidney Int Rep · 2026-05-15

单中心回顾性研究纳入50例成人活体供肾移植受者,按移植后3个月及后续活检酪氨酸羟化酶(TH)免疫染色分为再生组、非再生组及组织学不可评估组。结果显示再生组1年与3年降压药需求更多(3年P=0.012),间质纤维化从7.78%进展至10.56%(P=0.037),并伴POSTN、PAI-1上调。

要点

  • 移植后3个月58%受者TH转阴,其中79%随后出现交感神经再支配。
  • 再生组3年降压药需求显著高于非再生组(P=0.012)。
  • 再生组间质纤维化显著进展(7.78%至10.56%,P=0.037)。

核心结论

  • 交感神经再支配与肾移植后更高的降压药负担及更明显的间质纤维化随时间进展相关。
  • 转录组可见POSTN与PAI-1上调,符合SASP相关促纤维化通路特征。
  • 作者认为结果应谨慎解读,属假设生成性研究。

研究设计与样本

  • 单中心回顾性研究,纳入50例成人活体供肾移植受者。
  • 依据3个月TH免疫染色及后续活检分为再生组、非再生组和组织学不可评估组。
  • 皮质间质纤维化用天狼星红形态计量定量,纤维化相关基因表达用NanoString Human Fibrosis V2 Panel评估。

主要发现

  • 所有移植物移植后即刻均见TH阳性纤维,3个月时58%(29/50)转为TH阴性。
  • 29例TH转阴者中79%(23/29)随后出现交感神经再支配,6/29持续TH阴性。
  • 降压药使用在3个月时短暂下降,随后增加,主要见于再生组。
  • 再生组1年和3年降压药需求多于非再生组(1年P=0.066;3年P=0.012)。
  • 再生组间质纤维化显著进展(7.78%至10.56%,P=0.037),非再生组保持稳定。

关键数值与推荐

  • 再生组定义:3个月TH阴性、此后TH阳性;非再生组:持续TH阴性。
  • 转录组分析在8例选定病例中进行,显示POSTN和PAI-1上调。
  • 纤维化定量采用天狼星红形态计量法。

临床怎么用

  • 对肾移植受者移植后降压药需求上升,可考虑交感神经再支配及间质纤维化进展的可能。
  • TH免疫染色联合纤维化定量或有助于识别纤维化进展风险较高的受者。
  • 目前证据尚不足以据此改变降压治疗策略,需前瞻性研究验证。

局限性

  • 非再生亚组样本量有限。
  • 缺乏功能验证。
  • 为单中心回顾性设计,结果属假设生成性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Sympathetic reinnervation after kidney transplantation has been demonstrated histologically and functionally, but its clinical and molecular consequences remain unclear. METHODS: In this single-center retrospective study, 50 adult living-donor kidney transplant recipients were evaluated. Based on tyrosine hydroxylase (TH) immunostaining at 3 months and subsequent biopsies, recipients were categorized into the following: regeneration group (TH-negative at 3 months and TH-positive thereafter), nonregeneration group (persistently TH-negative), and a histologically nonevaluable group (TH-positive from 3 months onward). Cortical interstitial fibrosis was quantified by Sirius Red morphometry, and fibrosis-related gene expression was assessed using NanoString Human Fibrosis V2 Panel. RESULTS: Although all grafts showed TH-positive fibers immediately after transplantation, 58% became TH-negative at 3 months (29/50). Among these, 79% later demonstrated sympathetic reinnervation (23/29), whereas 6/29 remained persistently TH-negative. Antihypertensive agent use transiently decreased at 3 months but subsequently increased, predominantly in regeneration group. At 1 and 3 years, regeneration group required more antihypertensive medications than nonregeneration group (1 year: P = 0.066; 3 years: P = 0.012). Interstitial fibrosis progressed significantly in the regeneration group (7.78% to 10.56%, P = 0.037) but remained stable in nonregeneration group. Transcriptomic analysis showed upregulation of periostin (POSTN) and plasminogen activator inhibitor-1 (PAI-1), factors associated with sympathetic activation and senescence-associated secretory phenotype (SASP) (analysis performed in 8 selected cases). CONCLUSION: Sympathetic reinnervation was observed together with higher antihypertensive medication burden and greater interstitial fibrosis over time, along with transcriptomic signatures consistent with SASP-related fibrogenic pathways. However, given limited size of the nonregeneration subgroup and lack of functional validation, these findings should be interpreted cautiously and regarded as hypothesis-generating.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Ohki Y, Kawabe M, Yamamoto I, et al. Sympathetic Reinnervation is Associated With Antihypertensive Treatment Burden and Interstitial Fibrosis After Kidney Transplantation. Kidney Int Rep. 2026. PMID: 42318535. doi:10.1016/j.ekir.2026.106597

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。